Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Labeller names
- 3
- Live patents
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: ANDA 2, NDA 2.
| Dosage form | NDCs |
|---|---|
| injection | 2 |
| solution | 2 |
| Route | NDCs |
|---|---|
| intravenous | 2 |
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| shorla oncology inc. | 2 |
| shorla oncology inc. | 1 |
| shorla oncology inc., | 1 |
Exclusivity
Patents and exclusivities
1| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11957681 | IMKELDIimatinib mesylate | product | Apr 2040 |
Catalogue
Marketed products
6Showing 4 of 6.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| IMKELDI | imatinib oral | solution, oral | 81927-201NDA |
| JYLAMVO | Methotrexate | solution, oral | 81927-204NDA |
| nelarabine | nelarabine | injection, intravenous | 81927-111ANDA |
| nelarabine | nelarabine | injection, intravenous | 81927-375ANDA |
Compare
Other companies listing nelarabine
- Novartis Pharmaceuticals Corporation20 sites · 210 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- ThermoFisher Scientific Cork0 sites · 8 NDC
Enquiry
Common questions
- Is Shorla Oncology Inc., FDA approved?
- Shorla Oncology Inc., holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Shorla Oncology Inc., make?
- 6 products are listed under Shorla Oncology Inc., in the openFDA NDC Directory, most often as injection; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.